Last reviewed · How we verify
NCT07050199
Risk Factors Affecting Mortality in Perforated Peptic Ulcer
trial testing Emergency laparotomy in Peptic Ulcers in 85 participants. Completed in 30 March 2023.
30 March 2023
Quick facts
| Lead sponsor | Maharajgunj Medical Campus |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 85 |
| Start date | 1 April 2022 |
| Primary completion | 30 March 2023 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- Emergency laparotomy
Conditions studied
- Peptic Ulcers — all drugs for Peptic Ulcers →
Sponsor
Maharajgunj Medical Campus — full company profile →
Who can join
Adults 15 to 75, any sex, with Peptic Ulcers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Perforation is one of the most severe and life-threatening complications of peptic ulcer disease. This study aims to evaluate the risk factors associated with postoperative morbidity and mortality in patients undergoing surgery for peptic ulcer perforation, with a focus on the timing of presentation, demographic variables, surgical delay, and their association with postoperative outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Predictors of postoperative complications after surgery for perforated peptic ulcer: a prospective study from a tertiary center of Nepal.
Koirala BH, Upadhya PS, Luitel P, Upreti S, et al · · 2026 · PMID 41496915 · DOI 10.1097/ms9.0000000000004564
Verify or expand the search:
- PubMed search for NCT07050199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Emergency laparotomy
Trials testing the same drug.
- NCT04696367 — Impact of Nutritional Deficit in Emergency Surgery · completed
- NCT03270930 — Operative Duration as a Predictor of Mortality in Pediatric Emergency Surgery · completed
Other Maharajgunj Medical Campus trials
Trials by the same sponsor.
- NCT07088575 — Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobilia · completed
- NCT07026721 — Comparative Analysis of RIRS Scoring System and Resorlu Unsal Stone Score (RUSS) for Predicting Stone-free Rate After Re · completed
- NCT06746207 — Evaluating Patient and Caregiver Satisfaction with the Informed Consent Process in Surgery · completed
- NCT07130422 — Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery · completed
- NCT06729931 — Quantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectional Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07050199 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maharajgunj Medical Campus
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07050199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing